Israel Archives | Page 4 of 4

RedHill Biopharma Announces Positive Top-line Results from YELIVA™ (ABC294640) Phase I Study in Advanced Solid Tumors

TEL-AVIV, Israel, Oct. 26 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced positive top-line results from the Phase I study with YELIVA™ (ABC294640) in patients with advanced solid [...]

FIMI Commences Cash Tender Offer for Gilat Satellite Networks Ltd.

TEL AVIV, Israel, Oct. 24 (Korea Bizwire) — FIMI Opportunity IV, L.P, FIMI Israel Opportunity IV, Limited Partnership, FIMI Opportunity V, L.P and FIMI Israel Opportunity Five, Limited Partnership (collectively “FIMI”), announced today that they have commenced a cash tender offer to purchase 5,166,348 ordinary shares of Gilat Satellite Networks Ltd. (“Gilat”) (Nasdaq:GILT) for $4.95 [...]